Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
Molavi Z, Razi S, Mirmotalebisohi SA, Adibi A, Sameni M, Karami F, Niazi V, Niknam Z, Aliashrafi M, Taheri M, Ghafouri-Fard S, Jeibouei S, Mahdian S, Zali H, Ranjbar MM, Yazdani M.
Molavi Z, et al. Among authors: yazdani m.
Biomed Pharmacother. 2021 Jun;138:111544. doi: 10.1016/j.biopha.2021.111544. Epub 2021 Mar 31.
Biomed Pharmacother. 2021.
PMID: 34311539
Free PMC article.